{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:09:40Z","timestamp":1789063780271,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether the addition of botulinum toxin type A (BTX) to celiac plexus block (CPB) is associated with improved analgesic outcomes in patients with pancreatic cancer pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single-center tertiary hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects<\/jats:title>\n                    <jats:p>A total of 60 patients with pancreatic cancer pain who underwent fluoroscopy-guided CPB between January 2022 and November 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients were divided into CPB only (n\u2009=\u200934) and CPB with BTX (n\u2009=\u200926) groups. Pain intensity (numerical rating scale, NRS), opioid consumption (morphine milligram equivalents, MME), and need for rescue interventions were assessed at 4, 8, and 12\u2009weeks. The primary outcome was the proportion of positive responders at 4\u2009weeks, defined as \u22652-point reduction in NRS from baseline, no increase in opioid use, and no additional interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The proportion of positive responders at 4\u2009weeks was significantly higher in the CPB\u2009+\u2009BTX group compared to the CPB only group (65.4% vs 8.8%, P\u2009&amp;lt;\u2009.001), with sustained differences at 8 and 12\u2009weeks. The CPB\u2009+\u2009BTX group showed significantly lower pain scores at all follow-up time points and required fewer rescue interventions, including no cases of neurolysis. Kaplan-Meier analysis demonstrated a longer duration of analgesic response in the CPB\u2009+\u2009BTX group (P\u2009&amp;lt;\u2009.001). In multivariable analysis, BTX use was independently associated with treatment success (OR = 20.75, P\u2009&amp;lt;\u2009.001), while distant metastasis was a negative predictor. No serious adverse events were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CPB with BTX was associated with improved analgesic outcomes for pancreatic cancer pain compared to CPB only. The addition of BTX resulted in higher responder rates, sustained pain reduction, and reduced need for rescue interventions. BTX may represent a non-destructive adjunct to CPB and warrants further prospective validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pm\/pnag108","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:47:42Z","timestamp":1787312862000},"source":"Crossref","is-referenced-by-count":0,"title":["Celiac plexus block with versus without botulinum toxin type A for pancreatic cancer pain: a retrospective comparative study"],"prefix":"10.1093","author":[{"given":"Kaehong","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul National University Hospital , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungpyo","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul National University Hospital , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungcheol","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul National University Hospital , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-7356","authenticated-orcid":false,"given":"Jeongsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul National University Hospital , Seoul,","place":["Republic of Korea"]},{"name":"Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"2026091013513597900_pnag108-B1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10620-017-4488-z","article-title":"Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments","volume":"62","author":"Koulouris","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2026091013513597900_pnag108-B2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/jp9.0000000000000140","article-title":"Pancreatic cancer-related pain: mechanism and management","volume":"6","author":"Wu","year":"2023","journal-title":"J Pancreatol"},{"key":"2026091013513597900_pnag108-B3","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/cam4.4610","article-title":"Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015","volume":"11","author":"Lu","year":"2022","journal-title":"Cancer Med"},{"key":"2026091013513597900_pnag108-B4","doi-asserted-by":"publisher","first-page":"CD007519","DOI":"10.1002\/14651858.CD007519.pub2","article-title":"Celiac plexus block for pancreatic cancer pain in adults","volume":"2011","author":"Arcidiacono","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091013513597900_pnag108-B5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/s0885-3924(01)00338-4","article-title":"Increasing the efficacy of a celiac plexus block in patients with severe pancreatic cancer pain","volume":"22","author":"Vranken","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"2026091013513597900_pnag108-B6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/rapm-2024-105593","article-title":"Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections - guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society","volume":"51","author":"Benzon","year":"2026","journal-title":"Reg Anesth Pain Med"},{"key":"2026091013513597900_pnag108-B7","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jama.291.9.1092","article-title":"Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"2026091013513597900_pnag108-B8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1529-8027.2006.00103.x","article-title":"Nerve root degeneration and regeneration by intrathecal phenol in rats: a morphologic approach","volume":"11","author":"Romero-Figueroa","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"2026091013513597900_pnag108-B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/014107689308600507","article-title":"Incidence of major complications of neurolytic coeliac plexus block","volume":"86","author":"Davies","year":"1993","journal-title":"J R Soc Med"},{"key":"2026091013513597900_pnag108-B10","doi-asserted-by":"publisher","first-page":"E265","DOI":"10.1055\/s-0032-1309708","article-title":"Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis","volume":"44","author":"Fujii","year":"2012","journal-title":"Endoscopy"},{"key":"2026091013513597900_pnag108-B11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3344\/kjp.2018.31.1.50","article-title":"Transient paraplegia after neurolytic splanchnic block in a patient with metastatic colon carcinoma","volume":"31","author":"Oguz","year":"2018","journal-title":"Korean J Pain"},{"key":"2026091013513597900_pnag108-B12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026091013513597900_pnag108-B13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.disamonth.2016.05.011","article-title":"Botulinum toxin for chronic pain conditions","volume":"62","author":"Kermen","year":"2016","journal-title":"Dis Mon"},{"key":"2026091013513597900_pnag108-B14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s1566-0702(02)00093-0","article-title":"Effects of botulinum toxin type A on the superior cervical ganglia in rabbits","volume":"102","author":"Kim","year":"2002","journal-title":"Auton Neurosci"},{"key":"2026091013513597900_pnag108-B15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/aln.0000000000004084","article-title":"Botulinum toxin type A for lumbar sympathetic ganglion block in complex regional pain syndrome: a randomized trial","volume":"136","author":"Yoo","year":"2022","journal-title":"Anesthesiology"},{"key":"2026091013513597900_pnag108-B16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/jcpt.13180","article-title":"Celiac plexus block with botulinum toxin in severe chronic pancreatitis: a case report","volume":"45","author":"Cho","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"2026091013513597900_pnag108-B17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/pm\/pnae066","article-title":"Novel use of botulinum toxin A in celiac plexus block for management of chronic focal abdominal pain","volume":"25","author":"Shoham","year":"2024","journal-title":"Pain Med"},{"key":"2026091013513597900_pnag108-B18","doi-asserted-by":"publisher","first-page":"3000605241270677","DOI":"10.1177\/03000605241270677","article-title":"Efficacy of botulinum toxin injection using the right-sided unilateral retrocrural approach for celiac plexus in a cancer survivor with persistent abdominal pain: a case report","volume":"52","author":"Yu","year":"2024","journal-title":"J Int Med Res"},{"key":"2026091013513597900_pnag108-B19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2026091013513597900_pnag108-B20","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1097\/PR9.0000000000000930","article-title":"Celiac plexus neurolysis for abdominal cancers: going beyond pancreatic cancer pain","volume":"6","author":"Ambai","year":"2021","journal-title":"Pain Rep"},{"key":"2026091013513597900_pnag108-B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2013 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2026091013513597900_pnag108-B22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"2026091013513597900_pnag108-B23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/pm\/pnae038","article-title":"Evaluation of thoracic sympathetic ganglion block as a predictor for response to ketamine infusion therapy and spinal cord stimulation in patients with chronic upper extremity pain","volume":"25","author":"Kim","year":"2024","journal-title":"Pain Med"},{"key":"2026091013513597900_pnag108-B24","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/pme.12176","article-title":"Celiac plexus neurolysis for abdominal cancer pain: a systematic review","volume":"14","author":"Nagels","year":"2013","journal-title":"Pain Med"},{"key":"2026091013513597900_pnag108-B25","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"2026091013513597900_pnag108-B26","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1200\/jco.2010.32.2750","article-title":"Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer","volume":"29","author":"Wyse","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026091013513597900_pnag108-B27","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00520-018-4043-2","article-title":"Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing","volume":"26","author":"Yoon","year":"2018","journal-title":"Support Care Cancer"},{"key":"2026091013513597900_pnag108-B28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12871-025-03045-7","article-title":"A single-blind randomized controlled trial of celiac plexus block for analgesia after Whipple surgery","volume":"25","author":"Li","year":"2025","journal-title":"BMC Anesthesiol"},{"key":"2026091013513597900_pnag108-B29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cgh.2011.09.006","article-title":"Adding triamcinolone to endoscopic ultrasound-guided celiac plexus blockade does not reduce pain in patients with chronic pancreatitis","volume":"10","author":"Stevens","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091013513597900_pnag108-B30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pan.2020.12.016","article-title":"Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) technique and analgesic efficacy in patients with pancreatic cancer: a systematic review and meta-analysis","volume":"21","author":"Koulouris","year":"2021","journal-title":"Pancreatology"},{"key":"2026091013513597900_pnag108-B31","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/papr.13143","article-title":"Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer","volume":"22","author":"Okita","year":"2022","journal-title":"Pain Pract"},{"key":"2026091013513597900_pnag108-B32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1526-4637.2006.00216.x","article-title":"Botulinum toxin\u2014a treatment for migraine? A systematic review","volume":"7","author":"Gupta","year":"2006","journal-title":"Pain Med"},{"key":"2026091013513597900_pnag108-B33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41582-024-01002-5","article-title":"Insights from 25 years of onabotulinumtoxinA in migraine\u2014mechanisms and management","volume":"20","author":"Pozo-Rosich","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"2026091013513597900_pnag108-B34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.21601","article-title":"Sympathetic block with botulinum toxin to treat complex regional pain syndrome","volume":"65","author":"Carroll","year":"2009","journal-title":"Ann Neurol"},{"key":"2026091013513597900_pnag108-B35","first-page":"E911","article-title":"Lumbar sympathetic block with botulinum toxin type B for complex regional pain syndrome: a case study","volume":"18","author":"Choi","year":"2015","journal-title":"Pain Phys"},{"key":"2026091013513597900_pnag108-B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3344\/kjp.2010.23.1.65","article-title":"Ganglion impar block with botulinum toxin type A for chronic perineal pain: a case report","volume":"23","author":"Lim","year":"2010","journal-title":"Korean J Pain"},{"key":"2026091013513597900_pnag108-B37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/aln.0000000000004093","article-title":"Prolonging sympathetic blockade for complex regional pain syndrome: is botulinum toxin the answer?","volume":"136","author":"Singh","year":"2022","journal-title":"Anesthesiology"},{"key":"2026091013513597900_pnag108-B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"2026091013513597900_pnag108-B39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1558944721994250","article-title":"Botulinum toxin A and B improve perfusion, increase flap survival, cause vasodilation, and prevent thrombosis: a systematic review and meta-analysis of controlled animal studies","volume":"18","author":"Goldberg","year":"2023","journal-title":"Hand (NY)"},{"key":"2026091013513597900_pnag108-B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/wrr.12501","article-title":"Effect of botulinum toxin A on vasoconstriction and sympathetic neurotransmitters in a murine random pattern skin flap model","volume":"25","author":"Roh","year":"2017","journal-title":"Wound Repair Regen"},{"key":"2026091013513597900_pnag108-B41","doi-asserted-by":"publisher","first-page":"513.e1","DOI":"10.1016\/j.jhsa.2020.11.005","article-title":"The effects of botulinum toxin A on pain in ischemic vasospasm","volume":"46","author":"Goldberg","year":"2021","journal-title":"J Hand Surg Am"},{"key":"2026091013513597900_pnag108-B42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.semarthrit.2011.07.006","article-title":"Botulinum toxin A treatment of Raynaud\u2019s phenomenon: a review","volume":"41","author":"Iorio","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2026091013513597900_pnag108-B43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0304-3959(93)90130-h","article-title":"Celiac plexus block versus analgesics in pancreatic cancer pain","volume":"52","author":"Mercadante","year":"1993","journal-title":"Pain"},{"key":"2026091013513597900_pnag108-B44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.4251\/wjgo.v8.i8.599","article-title":"Road map for pain management in pancreatic cancer: a review","volume":"8","author":"Lahoud","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"2026091013513597900_pnag108-B45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3748\/wjg.v27.i1.69","article-title":"Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy","volume":"27","author":"Han","year":"2021","journal-title":"World J Gastroenterol"},{"key":"2026091013513597900_pnag108-B46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3344\/kjp.2021.34.4.479","article-title":"Factors associated with successful response to neurolytic celiac plexus block in patients with upper abdominal cancer-related pain: a retrospective study","volume":"34","author":"Kwon","year":"2021","journal-title":"Korean J Pain"},{"key":"2026091013513597900_pnag108-B47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3344\/kjp.24373","article-title":"Evaluation of the efficacy of the lumbar sympathetic ganglion block and the use of perfusion index as a predictor of its technical success: a prospective observational study","volume":"38","author":"Nam","year":"2025","journal-title":"Korean J Pain"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnag108\/70765585\/pnag108.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnag108\/70765585\/pnag108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:51:44Z","timestamp":1789062704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article\/doi\/10.1093\/pm\/pnag108\/8768885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1093\/pm\/pnag108","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"article-number":"pnag108"}}